BlackRock’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-327
| Closed | -$850 | – | 5363 |
|
|
2024
Q1 | $850 | Sell |
327
-14
| -4% | -$36 | ﹤0.01% | 5148 |
|
|
2023
Q4 | $1.23K | Hold |
341
| – | – | ﹤0.01% | 5182 |
|
|
2023
Q3 | $1.77K | Hold |
341
| – | – | ﹤0.01% | 5235 |
|
|
2023
Q2 | $2.91K | Sell |
341
-2,120
| -86% | -$18.1K | ﹤0.01% | 5263 |
|
|
2023
Q1 | $29K | Buy |
2,461
+68
| +3% | +$802 | ﹤0.01% | 5122 |
|
|
2022
Q4 | $34.5K | Buy |
2,393
+45
| +2% | +$648 | ﹤0.01% | 5218 |
|
|
2022
Q3 | $117K | Buy |
2,348
+123
| +6% | +$6.13K | ﹤0.01% | 5044 |
|
|
2022
Q2 | $189K | Sell |
2,225
-11,273
| -84% | -$958K | ﹤0.01% | 4957 |
|
|
2022
Q1 | $2.04M | Buy |
13,498
+305
| +2% | +$46.1K | ﹤0.01% | 4298 |
|
|
2021
Q4 | $3.95M | Buy |
13,193
+282
| +2% | +$84.3K | ﹤0.01% | 4031 |
|
|
2021
Q3 | $5.04M | Buy |
12,911
+363
| +3% | +$142K | ﹤0.01% | 3898 |
|
|
2021
Q2 | $5.3M | Buy |
12,548
+7,359
| +142% | +$3.11M | ﹤0.01% | 3791 |
|
|
2021
Q1 | $2.52M | Buy |
+5,189
| New | +$2.52M | ﹤0.01% | 4154 |
|